Annick Verhee

2.0k total citations
41 papers, 1.7k citations indexed

About

Annick Verhee is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Annick Verhee has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Immunology and 13 papers in Oncology. Recurrent topics in Annick Verhee's work include Immune Cell Function and Interaction (8 papers), Regulation of Appetite and Obesity (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Annick Verhee is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Regulation of Appetite and Obesity (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Annick Verhee collaborates with scholars based in Belgium, France and Germany. Annick Verhee's co-authors include Jan Tavernier, Joël Vandekerckhove, Sven Eyckerman, José Van der Heyden, Frank Peelman, D. Broekaert, Irma Lemmens, Xaveer Van Ostade, Geert Plaetinck and René Devos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Annick Verhee

40 papers receiving 1.6k citations

Peers

Countries citing papers authored by Annick Verhee

Since Specialization

Citations

This map shows the geographic impact of Annick Verhee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annick Verhee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annick Verhee more than expected).

Fields of papers citing papers by Annick Verhee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annick Verhee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annick Verhee. The network helps show where Annick Verhee may publish in the future.

Co-authorship network of co-authors of Annick Verhee

This figure shows the co-authorship network connecting the top 25 collaborators of Annick Verhee. A scholar is included among the top collaborators of Annick Verhee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annick Verhee. Annick Verhee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CCR1 inhibition sensitizes multiple myeloma cells to glucocorticoid therapy 2025 ·Pharmacological Research ·(unknown), (unknown), (unknown), (unknown), Annick Verhee, (unknown), Sven Eyckerman, Fritz Offner, Pieter Van Vlierberghe, (unknown), Dorien Clarisse, Karolien De Bosscher	0
2	Selective Modulation of the Human Glucocorticoid Receptor Compromises GR Chromatin Occupancy and Recruitment of p300/CBP and the Mediator Complex 2024 ·Molecular & Cellular Proteomics ·(unknown), Annick Verhee, (unknown), René Houtman, Diana Melchers, (unknown), (unknown), (unknown), Kris Gevaert, Sven Eyckerman, Karolien De Bosscher	6
3	Leveraging a self-cleaving peptide for tailored control in proximity labeling proteomics 2024 ·Cell Reports Methods ·(unknown), (unknown), Daria Fijałkowska, Annick Verhee, Delphine De Sutter, (unknown), (unknown), (unknown), (unknown), Karolien De Bosscher, Thomas L. Jacobs, Sven Eyckerman	5
4	A bispecific Clec9A-PD-L1 targeted type I interferon profoundly reshapes the tumor microenvironment towards an antitumor state 2023 ·Molecular Cancer ·Sandra Van Lint, Alexander Van Parys, (unknown), Niels Vandamme, Stéphane Plaisance, Annick Verhee, Dominiek Catteeuw, Elke Rogge, (unknown), (unknown), (unknown), Yvan Saeys, Gilles Uzé, (unknown), Anje Cauwels, Jan Tavernier	6
5	Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice 2018 ·Journal of Autoimmunity ·Anje Cauwels, Sandra Van Lint, Dominiek Catteeuw, (unknown), Franciane Paul, Elke Rogge, Annick Verhee, Marco Prinz, (unknown), Gilles Uzé, Jan Tavernier	20
6	Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments 2017 ·Cancer Research ·Anje Cauwels, Sandra Van Lint, Franciane Paul, Geneviève Garcin, Stefaan De Koker, Alexander Van Parys, (unknown), Sarah Gerlo, José Van der Heyden, Yann Bordat, Dominiek Catteeuw, Elke Rogge, Annick Verhee, Bart Vandekerckhove, (unknown), Gilles Uzé, Jan Tavernier	75
7	Trapping mammalian protein complexes in viral particles 2016 ·Nature Communications ·Sven Eyckerman, (unknown), (unknown), (unknown), Annick Verhee, (unknown), Leentje De Ceuninck, Evy Timmerman, Delphine De Sutter, Sam Lievens, Serge Van Calenbergh, Kris Gevaert, Jan Tavernier	34
8	Leptin’s metabolic and immune functions can be uncoupled at the ligand/receptor interaction level 2014 ·Cellular and Molecular Life Sciences ·Lennart Zabeau, Cathy Jensen, (unknown), Koen Venken, Annick Verhee, Dominiek Catteeuw, Geert Loo, Hui Chen, Ken Walder, Jacob H. Hollis, Simon J. Foote, Margaret J. Morris, José Van der Heyden, Frank Peelman, Brian J. Oldfield, Justin P. Rubio, Dirk Elewaut, Jan Tavernier	15
9	MAPPIT (MAmmalian Protein–Protein Interaction Trap) as a tool to study HIV reverse transcriptase dimerization in intact human cells 2008 ·Journal of Virological Methods ·Els Pattyn, Delphine Lavens, José Van der Heyden, Annick Verhee, Sam Lievens, Irma Lemmens, Sabine Hallenberger, Dirk Jochmans, Jan Tavernier	15
10	HyperISGylation of Old World Monkey ISG15 in Human Cells 2008 ·PLoS ONE ·Els Pattyn, Annick Verhee, (unknown), Julie Piessevaux, Evy Timmerman, Kris Gevaert, Joël Vandekerckhove, Frank Peelman, Jan Tavernier	17
11	Phosphorylation by Protein Kinase CK2 Modulates the Activity of the ATP Binding Cassette A1 Transporter 2004 ·Journal of Biological Chemistry ·(unknown), Frank Peelman, Annick Verhee, Christine Labeur, Hans Caster, Marc F. Lensink, Claudia Cirulli, Johan Grooten, Claude Cochet, Joël Vandekerckhove, Angela Amoresano, Giovanna Chimini, Jan Tavernier, Maryvonne Rosseneu	57
12	Neutralizing monoclonal antibodies can potentiate IL-5 signaling 2001 ·European Journal of Immunology ·Lennart Zabeau, José Van der Heyden, D. Broekaert, Annick Verhee, Joël Vandekerckhove, (unknown), Irwin Chaiken, Peter C. Heinrich, Iris Behrmann, Jan Tavernier	14
13	A Hydrophobic Cluster at the Surface of the Human Plasma Phospholipid Transfer Protein Is Critical for Activity on High Density Lipoproteins 2001 ·Journal of Biological Chemistry ·Catherine Desrumaux, Christine Labeur, Annick Verhee, Jan Tavernier, Joël Vandekerckhove, Maryvonne Rosseneu, Frank Peelman	26
14	Design and application of a cytokine-receptor-based interaction trap 2001 ·Nature Cell Biology ·Sven Eyckerman, Annick Verhee, José Van der Heyden, Irma Lemmens, Xaveer Van Ostade, Joël Vandekerckhove, Jan Tavernier	160
15	A Sensitive and Versatile Bioassay for Ligands That Signal Through Receptor Clustering 2000 ·Journal of Interferon & Cytokine Research ·Xaveer Van Ostade, (unknown), Els Pattyn, Annick Verhee, Joël Vandekerckhove, (unknown)	7
16	Headgroup specificity of lecithin cholesterol acyltransferase for monomeric and vesicular phospholipids 2000 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Bart Christiaens, Berlinda Vanloo, Catherine Gouyette, (unknown), Hans Caster, (unknown), Annick Verhee, Christine Labeur, Frank Peelman, (unknown), Jan Tavernier, Maryvonne Rosseneu	8
17	Dimerization of the Interferon Type I Receptor IFNaR2–2 Is Sufficient for Induction of Interferon Effector Genes but Not for Full Antiviral Activity 1999 ·Journal of Biological Chemistry ·Els Pattyn, Xaveer Van Ostade, (unknown), Annick Verhee, Michaël Kalai, Joël Vandekerckhove, Jan Tavernier	27
18	Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT) 1999 ·Protein Engineering Design and Selection ·Frank Peelman, Berlinda Vanloo, Óscar Pérez‐Méndez, (unknown), (unknown), Christine Labeur, N Vinaimont, Annick Verhee, Nicolas Duverger, Robert Brasseur, Joël Vandekerckhove, Jan Tavernier, Maryvonne Rosseneu	29
19	The cell surface expression level of the human interleukin‐5 receptor α subunit determines the agonistic/antagonistic balance of the human interleukin‐5 E13Q mutein 1999 ·European Journal of Biochemistry ·Xaveer Van Ostade, José Van der Heyden, Annick Verhee, Joël Vandekerckhove, Jan Tavernier	5
20	A proposed architecture for lecithin cholesterol acyl transferase (LCAT): Identification of the catalytic triad and molecular modeling 1998 ·Protein Science ·Frank Peelman, N Vinaimont, Berlinda Vanloo, Christine Labeur, M. Rosseneu, Annick Verhee, (unknown), (unknown), Jan Tavernier, (unknown), Nicolas Duverger, Gillian Hutchinson	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact